Literature DB >> 35363868

A Tale of Two Histologies: Dissecting the Biology of Lineage Transformation in Lung Cancer.

Catherine B Meador1, Christine M Lovly2.   

Abstract

SUMMARY: Lineage plasticity is an important, and likely underappreciated, mechanism of treatment resistance in lung cancer. Here, Quintanal-Villalonga and colleagues integrate results from multiomic analyses to provide key new insights into the biology of lineage plasticity. See related article by Quintanal-Villalonga et al., p. 3028. ©2021 American Association for Cancer Research.

Entities:  

Mesh：

Year:  2021        PMID： 35363868      PMCID： PMC8988434          DOI： 10.1158/2159-8290.CD-21-1222

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   38.272


  10 in total

1.  EGFR mutations in small-cell lung cancers in patients who have never smoked.

Authors:  Maureen F Zakowski; Marc Ladanyi; Mark G Kris
Journal:  N Engl J Med       Date:  2006-07-13       Impact factor: 91.245

2.  Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes.

Authors:  Michael Offin; Joseph M Chan; Megan Tenet; Hira A Rizvi; Ronglai Shen; Gregory J Riely; Natasha Rekhtman; Yahya Daneshbod; Alvaro Quintanal-Villalonga; Alexander Penson; Matthew D Hellmann; Maria E Arcila; Marc Ladanyi; Dana Pe'er; Mark G Kris; Charles M Rudin; Helena A Yu
Journal:  J Thorac Oncol       Date:  2019-06-19       Impact factor: 15.609

3.  A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib.

Authors:  Yoon Jin Cha; Byoung Chul Cho; Hye Ryun Kim; Hye-Jeong Lee; Hyo Sup Shim
Journal:  J Thorac Oncol       Date:  2015-12-29       Impact factor: 15.609

Review 4.  Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas.

Authors:  William D Travis
Journal:  Mod Pathol       Date:  2012-01       Impact factor: 7.842

5.  EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes.

Authors:  Nicolas Marcoux; Scott N Gettinger; Grainne O'Kane; Kathryn C Arbour; Joel W Neal; Hatim Husain; Tracey L Evans; Julie R Brahmer; Alona Muzikansky; Philip D Bonomi; Salvatore Del Prete; Anna Wurtz; Anna F Farago; Dora Dias-Santagata; Mari Mino-Kenudson; Karen L Reckamp; Helena A Yu; Heather A Wakelee; Frances A Shepherd; Zofia Piotrowska; Lecia V Sequist
Journal:  J Clin Oncol       Date:  2018-12-14       Impact factor: 44.544

6.  Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas.

Authors:  June-Koo Lee; Junehawk Lee; Sehui Kim; Soyeon Kim; Jeonghwan Youk; Seongyeol Park; Yohan An; Bhumsuk Keam; Dong-Wan Kim; Dae Seog Heo; Young Tae Kim; Jin-Soo Kim; Se Hyun Kim; Jong Seok Lee; Se-Hoon Lee; Keunchil Park; Ja-Lok Ku; Yoon Kyung Jeon; Doo Hyun Chung; Peter J Park; Joon Kim; Tae Min Kim; Young Seok Ju
Journal:  J Clin Oncol       Date:  2017-05-12       Impact factor: 44.544

7.  Small Cell Lung Cancer Transformation as a Mechanism of Resistance to PD-1 Therapy in KRAS-Mutant Lung Adenocarcinoma: A Report of Two Cases.

Authors:  Wade T Iams; Kathryn E Beckermann; Karinna Almodovar; Jennifer Hernandez; Cindy Vnencak-Jones; Lee P Lim; Christopher K Raymond; Leora Horn; Christine M Lovly
Journal:  J Thorac Oncol       Date:  2018-12-10       Impact factor: 15.609

8.  Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer.

Authors:  Adam J Schoenfeld; Joseph M Chan; Daisuke Kubota; Hiroki Sato; Hira Rizvi; Yahya Daneshbod; Jason C Chang; Paul K Paik; Michael Offin; Maria E Arcila; Monika A Davare; Ujwal Shinde; Dana Pe'er; Natasha Rekhtman; Mark G Kris; Romel Somwar; Gregory J Riely; Marc Ladanyi; Helena A Yu
Journal:  Clin Cancer Res       Date:  2020-01-07       Impact factor: 12.531

9.  Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.

Authors:  Himisha Beltran; Davide Prandi; Juan Miguel Mosquera; Matteo Benelli; Loredana Puca; Joanna Cyrta; Clarisse Marotz; Eugenia Giannopoulou; Balabhadrapatruni V S K Chakravarthi; Sooryanarayana Varambally; Scott A Tomlins; David M Nanus; Scott T Tagawa; Eliezer M Van Allen; Olivier Elemento; Andrea Sboner; Levi A Garraway; Mark A Rubin; Francesca Demichelis
Journal:  Nat Med       Date:  2016-02-08       Impact factor: 53.440

10.  Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation.

Authors:  Alvaro Quintanal-Villalonga; Hirokazu Taniguchi; Yingqian A Zhan; Maysun M Hasan; Shweta S Chavan; Fanli Meng; Fathema Uddin; Parvathy Manoj; Mark T A Donoghue; Helen H Won; Joseph M Chan; Metamia Ciampricotti; Andrew Chow; Michael Offin; Jason C Chang; Jordana Ray-Kirton; Sam E Tischfield; Jacklynn Egger; Umesh K Bhanot; Irina Linkov; Marina Asher; Sonali Sinha; Joachim Silber; Christine A Iacobuzio-Donahue; Michael H Roehrl; Travis J Hollmann; Helena A Yu; Juan Qiu; Elisa de Stanchina; Marina K Baine; Natasha Rekhtman; John T Poirier; Brian Loomis; Richard P Koche; Charles M Rudin; Triparna Sen
Journal:  Cancer Discov       Date:  2021-12-01       Impact factor: 38.272
  10 in total
  1 in total

1.  Identidication of novel biomarkers in non-small cell lung cancer using machine learning.

Authors:  Fangwei Wang; Qisheng Su; Chaoqian Li
Journal:  Sci Rep       Date:  2022-10-06       Impact factor: 4.996
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.